7 results
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
, the Corporation is subject to the disclosure requirements of the Canada Business Corporations Act with respect to diversity. The required disclosure … , diversity of views and up-to-date perceptions to the Board and its deliberations. It is the mandate of the Governance Committee to identify and recommend
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
22 Aug 22
Current report (foreign)
11:39am
to diversity. The required disclosure is attached hereto as Appendix “A”.
RECEIPT OF SHAREHOLDER PROPOSALS FOR 2023 ANNUAL MEETING
Under the Canada Business … a capacity to provide additional strength, diversity of views and up-to-date perceptions to the Board and its deliberations. It is the mandate
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
1 Sep 21
Current report (foreign)
8:00am
to the disclosure requirements of the CBCA with respect to diversity. The required disclosure is attached hereto as Appendix “A”.
RECEIPT OF SHAREHOLDER … and social issues, both nationally and internationally. This implies a capacity to provide additional strength, diversity of views and up-to-date
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
4 Sep 20
Current report (foreign)
2:50pm
is subject to the disclosure requirements of the CBCA with respect to diversity. The required disclosure is attached hereto as Appendix “A”.
RECEIPT … to deal with business, financial and social issues, both nationally and internationally. This implies a capacity to provide additional strength, diversity
S-8
EX-99.4
t1n7gup 4tlb
31 Jul 20
Registration of securities for employees
8:43am
F-10
EX-4.4
w1kdmsyd6kks
3 Jun 20
Registration of securities (Canada)
3:54pm
- Prev
- 1
- Next